Cleared Traditional

K063813 - VENTLAB NASAL CO2 SAMPLING/O2 DELIVERY ...

K063813 is an FDA 510(k) clearance for VENTLAB NASAL CO2 SAMPLING/O2 DELIVERY ..., manufactured by Ventlab Corp.. The device is a Class 2 Anesthesiology device with product code CCK cleared through the Traditional 510(k) pathway after a 460-day FDA review.

K063813 · Ventlab Corp. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2008
Decision
460d
Days
Class 2
Risk

K063813 is an FDA 510(k) clearance for the VENTLAB NASAL CO2 SAMPLING/O2 DELIVERY CANNULA. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Ventlab Corp. (Mocksville, US). The FDA issued a Cleared decision on March 26, 2008 after a review of 460 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Anesthesiology submissions.

View all Ventlab Corp. devices

FDA 510(k) Submission Details - K063813

510(k) Number K063813 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 22, 2006
Decision Date March 26, 2008
Days to Decision 460 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
320d slower than avg
Panel avg: 140d · This submission: 460d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCK Device Classification - Class 2, Special Controls

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 154
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K063813.
END TIDAL CO2 NASAL CANNULA
K120518 · Care Fusion · May 2012
ACE/STATCHECK II CO2 INDICATOR, ACE/STATCHECK II CO2 INDICATOR ARM ASSEMBY ADULT STATCHECK RESUSCITATOR WITH ACE/STATCHE
K093525 · Ventlab Corp. · Dec 2009
NIHON KOHDEN CO2 SENSOR KIT, MODEL TG-970P
K083456 · Nihon Kohden America, Inc. · Mar 2009
YG-125T AND YG-135T NASAL ADAPTER
K072843 · Nihon Kohden America, Inc. · Nov 2007
CARBON DIOXIDE MONITOR, MODEL OLG-2800A
K062115 · Nihon Kohden America, Inc. · Dec 2006
DATEX-OHMEDA S/5 INTERFACE MODULE E-INT
K052880 · Ge Healthcare · Nov 2005